Cecilia O. Vega

• Alumni Leadership Award, GEM Consortium
• Leading IP Strategist, Intellectual Asset Management (IAM)

• Prepared a distribution agreement for a European company who Cambridge engaged to sell its medical devices in Europe.

• Prepared a domestic sales representative agreement for a domestic company to promote the sales of its medical equipment within the United States.

• Acquisition by merger involving an electronics company that operates in the industrial and defense industries.

• Series B and Series C financings of an oncology therapeutics and a biotech company by major hedge funds.

• Representation of a healthcare-related software company in its investment in a private equity portfolio company.

• Sale of GE Life Sciences (Biopharma) business to Danaher $21B: IP Cross License Agreement, schedules and exclusive license, Transitional Trademark License Agreement, GE-owned Software license to Biopharma, GE Global Research Agreements.

• Sale of GE Life Sciences (Biopharma) Invitro Forensics business to Qiagen: Patent sale, patent license, resolved commitments under government contracts.

• Merger and sell down of GE’s interest in Baker Hughes $7.4B: Transaction Agreement and Plan of Merger, Digital Agreement, Intercompany Services Agreement, Non-compete Agreement and Supply Agreement.

• Sale of GE Water business to Suez Water Technologies $3.4B: Stock and Asset Purchase Agreement, GE Research Division Agreement (employment, data transfer, sale of equipment).

• Outsourcing of GE Corporate Tax division to PWC: Transaction Agreement, IP Transfer and License Agreement, Services Agreement and Escrow Agreement.

• Merger of Service Max with GE Digital business $915 MM: Merger Agreement including investment by GE Ventures unit, trademark, software review/remediation.

• Sale of GE Transportation to Wabtec: Formation of SpinCo, Merger Agreement, Separation Agreement, Horizontal IP License.

Other Representations

• Represent a cross-border life sciences company in connection with a series of licensing transactions of their core technology.

• Assisted a US-based medical device company with preparation of a distribution agreement with a European distributor.

• Agreements for GE Ventures (incubator and launch engine for startups and minority investments at GE), invitro diagnostics, aviation, oil & gas, digital and transportation technologies.

• Monetization of Life Sciences patents used in surgery, Investment in a healthcare consultancy with private equity, NIH research agreement and collaboration with GE Healthcare and GE Research divisions.

• Second chair in two federal patent trials in District of Delaware and Eastern district of PA.

• Drafted and prosecuted patents in mechanical and electrical fields.

• “Obtaining Investment for Life Sciences Companies: Best Practices for Securing Funding and Negotiating Term Sheets,” moderator, IPWatchdog Life Sciences Masters, October 2022.
• “Boston Firm Choate Adds Ex-GE Counsel To IP Group,” featured, Law360, June 2021.

• Co-chair, M&A Committee, American Intellectual Property Law Association
• Pro Bono Counsel, Youth Advocacy Foundation, Pro Bono Counsel, Boston, MA
• Counsel, representing Boston Public School special ed students in hearings, Edlaw Program, Disrupt School to Prison Pipeline
• Mentor, PowHERful Foundation, New York, NY
• Mentor to diverse law students and prospective students
• Board Chair, Trustee, and member of Governance, Business Development, Audit, Risk and Executive Committees, Woods Services, Langhorne, PA, a healthcare nonprofit for clinical care, educational/ residential services for adults and children with severe neurological disorders